← Back to directory

Pekka T. Männistö

Researcher Next ID · RN-039159

Researcher · Biochemistry, Genetics and Molecular Biology

University of Helsinki

Helsinki, Finland

Accepting doctoral researchersFunding unknown
Works count
469
Citation count
12,697
H-index
56
i10-index
245

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Neuroscience
Neuropeptides and Animal Physiology
Neuroscience and Neuropharmacology Research
Neurotransmitter Receptor Influence on Behavior
Peptidase Inhibition and Analysis
Receptor Mechanisms and Signaling

Publications

  • Catechol-O-methyltransferase gene polymorphism and chronic human pain

    Pharmacogenetics and Genomics · 2012 · 10.1097/fpc.0b013e3283560c46

  • Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease

    Experimental Neurology · 2010 · 10.1016/j.expneurol.2010.12.013

  • Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice

    Journal of Neurochemistry · 2010 · 10.1111/j.1471-4159.2010.06889.x

  • The multiple faces of quercetin in neuroprotection

    Expert Opinion on Drug Safety · 2009 · 10.1517/14740330903026944

  • Site-Specific Role of Catechol- O -Methyltransferase in Dopamine Overflow within Prefrontal Cortex and Dorsal Striatum

    Journal of Neuroscience · 2007 · https://doi.org/10.1523/jneurosci.0665-07.2007

  • Pharmacologically Diverse Antidepressants Rapidly Activate Brain-Derived Neurotrophic Factor Receptor TrkB and Induce Phospholipase-Cγ Signaling Pathways in Mouse Brain

    Neuropsychopharmacology · 2007 · https://doi.org/10.1038/sj.npp.1301345

  • On the role of prolyl oligopeptidase in health and disease

    Neuropeptides · 2006 · 10.1016/j.npep.2006.10.004

  • Dopamine supersensitivity correlates with D2 High states, implying many paths to psychosis

    Proceedings of the National Academy of Sciences · 2005 · https://doi.org/10.1073/pnas.0409766102

  • Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice

    European Journal of Neuroscience · 2002 · 10.1046/j.0953-816x.2001.01856.x

  • Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors

    Pharmacological Reviews · 1999 · https://doi.org/10.1016/s0031-6997(24)01423-6

  • 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety

    Psychopharmacology · 1997 · 10.1007/s002130050309

  • General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase

    General Pharmacology The Vascular System · 1994 · 10.1016/0306-3623(94)90082-5

  • Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors

    Birkhäuser Basel eBooks · 1992 · https://doi.org/10.1007/978-3-0348-7144-0_9

  • Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's Disease

    Pharmacology & Toxicology · 1990 · 10.1111/j.1600-0773.1990.tb00756.x

  • Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

    Journal of Medicinal Chemistry · 1989 · 10.1021/jm00124a017

  • New selective COMT inhibitors: useful adjuncts for Parkinson's disease?

    Trends in Pharmacological Sciences · 1989 · 10.1016/0165-6147(89)90075-8

  • Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat

    European Journal of Pharmacology · 1988 · 10.1016/0014-2999(88)90614-0

  • Neurotransmitter regulation of anterior pituitary hormones.

    PubMed · 1985

Current projects

    No projects listed.